Lotemax loteprednol etabonate data

PARS (New York) presented data from Phase III trials at the meeting of the Association for Research in Vision and Ophthalmology in Fort Lauderdale, Fla., showing efficacy of the Lotemax steroid.

In allergic eye inflammation, the drug was more effective than a placebo eye drop in alleviating symptoms and redness (p<0.001). ...